Symptoms of depression and anxiety and adherence to antihypertensive medication

American Journal of Hypertension

Volumn 25, Issue 4, 2012, Pages 505-511

  Bautista, Leonelo E ^a   Vera Cala, Lina M ^a,b   Colombo, Cynthia ^a   Smith, Paul ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSIDAD INDUSTRIAL DE SANTANDER   (Colombia)

Author keywords

anxiety; blood pressure; cohort studies; depression; hypertension; pateint non adherence

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; BECK DEPRESSION INVENTORY; COHORT ANALYSIS; DEPRESSION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SYMPTOM; WELLBEING;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; ANXIETY; DEPRESSION; FEMALE; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PATIENT COMPLIANCE;

EID: 84863416345     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1038/ajh.2011.256     Document Type: Article

References (39)

1. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010; 303:2043-2050.
2. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, Poulter N, Primatesta P, Stegmayr B, Thamm M. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004; 43:10-17. (Pubitemid 38031904)
3. Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 2008; 336:1114-1117. (Pubitemid 351731741)
4. Morgan SG, Yan L. Persistence with hypertension treatment among community-dwelling BC seniors. Can J Clin Pharmacol 2004; 11:e267-e273. (Pubitemid 46333123)
5. Oparil S, Calhoun DA. Managing the patient with hard-to-control hypertension. Am Fam Physician 1998; 57:1007-14, 1019-1020.
6. Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, Borghi C, Brignoli O, Caputi AP, Cricelli C, Mantovani LG. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 2009; 120:1598-1605.
7. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005; 43:521-530. (Pubitemid 40847288)
8. Dezii CM. A retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertension. Manag Care 2000; 9:2-6.
9. Bloom BS. Continuation of initial antihypertensive medication after 1 year of therapy. Clin Ther 1998; 20:671-681. (Pubitemid 28421488)
10. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160:2101-2107. (Pubitemid 30482715)
11. Morris AB, Li J, Kroenke K, Bruner-England TE, Young JM, Murray MD. Factors associated with drug adherence and blood pressure control in patients with hypertension. Pharmacotherapy 2006; 26:483-492.
12. Wang PS, Bohn RL, Knight E, Glynn RJ, Mogun H, Avorn J. Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med 2002; 17:504-511. (Pubitemid 34989157)
13. Bautista LE. Response to "depression and adherence to antihypertensive therapy". Am J Hypertens 2008; 21:726. (Pubitemid 351913628)
14. Beck AT, Steer RA, Brown GK. Manual for Beck Depression Inventory-II. Psychological Corporation: San Antonio, TX, 1996.
15. Arnau RC, Meagher MW, Norris MP, Bramson R. Psychometric evaluation of the Beck Depression Inventory-II with primary care medical patients. Health Psychol 2001; 20:112-119. (Pubitemid 32233867)
16. Dupuy HJ. Utility of the National Center for Health Statistics General Well-Being Schedule in the Assessment of Self-Representations of Subjective Well-Being and Distress. The national conference on evaluation in alcohol, drug abuse and mental health programs. ADAMHA: Washington, DC, 1974.
17. Anderson RB, Hollenberg NK, Williams GH. Physical Symptoms Distress Index: a sensitive tool to evaluate the impact of pharmacological agents on quality of life. Arch Intern Med 1999; 159:693-700. (Pubitemid 29177658)
18. Croog SH, Levine S, Testa MA, Brown B, Bulpitt CJ, Jenkins CD, Klerman GL, Williams GH. The effects of antihypertensive therapy on the quality of life. N Engl J Med 1986; 314:1657-1664. (Pubitemid 16097842)
19. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation 2005; 111:697-716. (Pubitemid 40216499)
20. O'Brien E, Mee F, Atkins N, Thomas M. Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: the Omron HEM-705CP, Philips HP5332, and Nissei DS-175. Blood Press Monit 1996; 1:55-61. (Pubitemid 126441351)
21. Ebrahim S. Detection, adherence and control of hypertension for the prevention of stroke: a systematic review. Health Technol Assess 1998; 2:i-iv, 1-78.
22. Collet D. Some non-parametric procedures. Modelling Survival Data in Medical Research. Chapman & Hall: New York, NY, 1994.
23. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989; 79:340-349. (Pubitemid 19077878)
24. Twisk JWR. Applied Longitudinal Data Analysis for Epidemiology: A Practical Guide. Cambridge University Press: Cambridge, UK, 2003.
25. Wang PS, Avorn J, Brookhart MA, Mogun H, Schneeweiss S, Fischer MA, Glynn RJ. Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives. Hypertension 2005; 46:273-279. (Pubitemid 41099157)
26. Siegel D, Lopez J, Meier J. Antihypertensive medication adherence in the Department of Veterans Affairs. Am J Med 2007; 120:26-32. (Pubitemid 46026987)
27. Bandura A. Self-efficacy. In Ramachaudran VS (ed), Encyclopedia of Human Behavior. Academic Press: New York, 1994.
28. Schoenthaler A, Ogedegbe G, Allegrante JP. Self-efficacy mediates the relationship between depressive symptoms and medication adherence among hypertensive African Americans. Health Educ Behav 2009; 36:127-137.
29. Bandura A, Pastorelli C, Barbaranelli C, Caprara GV. Self-efficacy pathways to childhood depression. J Pers Soc Psychol 1999; 76:258-269.
30. Muris P. Relationships between self-effcacy and symptoms of anxiety disorders and depression in a normal adolescent sample. Pers Individ Differ 2002; 32:337-348. (Pubitemid 39659735)
31. Wing RR, Phelan S, Tate D. The role of adherence in mediating the relationship between depression and health outcomes. J Psychosom Res 2002; 53:877-881. (Pubitemid 35282617)
32. Sacco WP, Wells KJ, Vaughan CA, Friedman A, Perez S, Matthew R. Depression in adults with type 2 diabetes: the role of adherence, body mass index, and self-efficacy. Health Psychol 2005; 24:630-634. (Pubitemid 41698173)
33. Stilley CS, Sereika S, Muldoon MF, Ryan CM, Dunbar-Jacob J. Psychological and cognitive function: predictors of adherence with cholesterol lowering treatment. Ann Behav Med 2004; 27:117-124. (Pubitemid 38364891)
34. Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med 1990; 150:1377-1378. (Pubitemid 20215672)
35. Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med 1990; 150:1509-1510. (Pubitemid 20215692)
36. Hamilton GA. Measuring adherence in a hypertension clinical trial. Eur J Cardiovasc Nurs 2003; 2:219-228. (Pubitemid 37153170)
37. Guerrero D, Rudd P, Bryant-Kosling C, Middleton B, Middleton BF [corrected to Middleton B. Antihypertensive medication-taking. Investigation of a simple regimen. Am J Hypertens 1993; 6:586-592. (Pubitemid 23248825)
38. Liu H, Golin CE, Miller LG, Hays RD, Beck CK, Sanandaji S, Christian J, Maldonado T, Duran D, Kaplan AH, Wenger NS. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med 2001; 134:968-977. (Pubitemid 32466236)
39. Morgado A, Raoux N, Smith M, Allilaire JF, Widlöcher D. Subjective bias in reports of poor work adjustment in depressed patients. Acta Psychiatr Scand 1989; 80:541-547. (Pubitemid 20046937)